Lexiscan & Adenoscan

The FDA has warned healthcare professionals about rare but severe risks associated with Lexiscan and Adenoscan, two drug agents used in cardiac nuclear stress tests for patients who cannot exercise adequately.

The drugs can help identify coronary artery disease by dilating the arteries of the heart and increasing blood flow to help find blocks or obstructions. Lexiscan and Adenoscan cause more blood to flow to healthier, unrestricted arteries, thereby reducing blood flow to obstructed arteries. In some rare cases, this reduced blood flow can lead to heart attack and death, among other potential side effects.

For patients taking Lexiscan, adverse effects associated with death included cardiac arrest, myocardial infarction, pulmonary edema, and respiratory arrest. For patients taking Adenoscan, adverse effects included cardiorespiratory arrest, dyspnea, cardiac arrest, and ventricular tachycardia.

If someone you know has suffered from a heart attack as a result of taking Lexiscan or Adenoscan, contact Law Offices of Gary Green to day to discuss your legal options without obligation. Call us toll-free at 1-888-4GARYGREEN or email us at ggreen@gGreen.com.

 

Print Friendly, PDF & Email